|
Autoantibody Profiling for Serological Detection of Head and Neck Cancer
|
1R43CA139806-01
|
$217,801
|
$43,560
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid
|
1R43CA141963-01
|
$183,927
|
$183,927
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
National Tobacco Cessation Collaborative - Youth Tobacco Cessation Collaborative
|
N02PC900209
|
$94,045
|
$94,045
|
UNKNOWN, UNKNOWN
|
Academy for Educational Development
|
|
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL EXPANSION F
|
N01CN075022-063
|
$1,617,215
|
$404,304
|
FOUAD, MONA
|
ALABAMA UNIV BIRMINGHAM:1109410
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$235,634
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Multiplex approach to DNA methylation assays in exhaled breath condensate
|
5R03CA132145-02
|
$83,000
|
$83,000
|
HAN, WEIGUO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-09
|
$264,921
|
$264,921
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Determinants of Resistance to Erlotinib in NSCLC
|
5R01CA113630-04
|
$286,106
|
$286,106
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Transition State Analogues as Modulators of DNA Methylation
|
5R01CA135405-02
|
$270,000
|
$270,000
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Exhaled Breath DNA Methylation in Lung Carcinogenesis
|
5R21CA121068-02
|
$186,817
|
$186,817
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Field of Injury Based Biomarkers for Lung Cancer
|
1R44CA139803-01A1
|
$277,875
|
$277,875
|
Brody, Jerome
|
ALLEGRO DIAGNOSTICS, INC.
|
|
"Alpha Particle-emitting Erb-2 Tumor-targeting Peptides" - Topic 255
|
N43CO900062-000
|
$150,000
|
$37,500
|
Testa, Richard
|
ALPHAMED INC:1120333
|
|
Identification of microRNA Biomarkers for Lung Cancer
|
1R43CA141786-01
|
$273,456
|
$273,456
|
Mambo, Elizabeth
|
AMBION DIAGNOSTICS, INC.
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
$877,421
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$3,189
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$201,970
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
5U24CA114734-05
|
$808,869
|
$80,887
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$1,112,049
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
|
5R01CA065435-11
|
$564,543
|
$112,909
|
WILSON, JESSE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
In vivo RNAi nanoparticle cancer gene function reagent
|
5R43CA137952-02
|
$235,400
|
$235,400
|
WOODLE, MARTIN
|
APARNA BIOSCIENCES CORPORATION
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
5R01CA090441-07
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effect of True Puff Profile Replication on Machine-Generated Smoke Constituents
|
1R21CA133893-01A1
|
$260,429
|
$247,408
|
Gordon, Sydney
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Smokers and PREPs: Measurement of Inhaled and Exhaled Tobacco Smoke Particulate
|
5R01CA129511-03
|
$377,968
|
$359,070
|
Gordon, Sydney
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Roll Your Own (RYO) Cigarettes: Prevalence, Smoking Behavior and Toxin Exposure
|
1R01CA138973-01
|
$407,794
|
$407,794
|
Pickworth, Wallace
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$46,908
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Reducing Missed And Delayed Diagnoses In Cancer: Lessons From Aviation
|
5K23CA125585-03
|
$141,750
|
$46,778
|
SINGH, HARDEEP
|
BAYLOR COLLEGE OF MEDICINE
|
|
Development of an HSV-2 based oncolytic virus
|
1R01CA132792-01A1
|
$202,620
|
$101,310
|
ZHANG, XIAOLIU
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$38,786
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$3,926
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Nicotine in Lung Carcinogenesis
|
5R01CA124490-03
|
$323,000
|
$323,000
|
CHEN, CHANGYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of EGFR mutations and new therapeutics in lung cancer
|
4R00CA126026-03
|
$249,000
|
$249,000
|
Kobayashi, Susumu
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The function of RhoBTB proteins
|
5R01CA113559-04
|
$293,000
|
$73,250
|
Soltoff, Stephen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Circulating Tumor Cells in Non-Small Cell Lung Cancer
|
5R01CA125653-03
|
$337,278
|
$337,278
|
Nieva, Jorge
|
BILLINGS CLINIC FOUNDATION
|
|
Standardized NanoArray PCR for Gene Expression Profiling of Lung Cancer
|
5R21CA132806-02
|
$173,300
|
$173,300
|
MORRISON, TOM
|
BIOTROVE, INC.
|
|
New Methods for Cancer Class Discovery and Prediction: Integration, visualization
|
5R21CA135882-02
|
$203,125
|
$67,031
|
DELISI, CHARLES
|
BOSTON UNIVERSITY
|
|
Disparities in Lung and Colorectal Cancers
|
5R03CA130067-02
|
$81,250
|
$40,625
|
Boehmer, Ulrike
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing
|
1R01CA141587-01
|
$699,337
|
$664,370
|
BROOKS, DANIEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
3R01CA112102-05S1
|
$56,604
|
$28,302
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
5R01CA112102-05
|
$302,435
|
$151,218
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer
|
5R01CA124640-03
|
$308,750
|
$308,750
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
|
5R01CA120528-04
|
$301,617
|
$301,617
|
BUENO, RAPHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases
|
5R01CA131044-02
|
$360,853
|
$360,853
|
COLSON, YOLONDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A multiplex genome-wide shRNA screening platform for cancer-lethal gene discovery
|
1R33CA140039-01
|
$361,095
|
$361,095
|
ELLEDGE, STEPHEN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
An Integrative Genomics Data Viewer to Support the TCGA Project
|
5R21CA135827-03
|
$205,500
|
$67,815
|
MESIROV, JILL
|
BROAD INSTITUTE, INC.
|
|
The Epidemiology of Molecular Alterations in Mesothelioma
|
5R01CA126939-02
|
$494,897
|
$494,897
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
Safety/Efficacy of Liposomal Reversan, a novel MRP1 modulator for Cancer Therapy
|
1R41CA137977-01
|
$104,608
|
$35,567
|
Sen, Arindam
|
BUFFALO BIOLABS, LLC
|
|
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers
|
3R01CA129226-02S1
|
$111,515
|
$111,515
|
STEIN, MICHAEL
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Varenicline versus Nicotine Replacement for Methadone-Maintained Smokers
|
5R01CA129226-02
|
$505,271
|
$505,271
|
STEIN, MICHAEL
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Spectrally resolved tomographic small-animal fluorescence imager
|
5R44CA138243-03
|
$875,689
|
$437,845
|
LEVENSON, RICHARD
|
CAMBRIDGE RESEARCH AND INSTRUMENTATION
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$75,698
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
Total relevant funding to Lung for this search: $246,936,061
|